# Management of Type 2 Diabetes After Gastric Bypass Surgery

> **NCT01213563** · NA · TERMINATED · sponsor: **Imperial College London** · enrollment: 50 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Actrapid insulin+Gloucose
- **DRUG:** Actrapid insulin

## Key facts

- **NCT ID:** NCT01213563
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Data were published that superseded this study.
- **Last updated:** 2020-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01213563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01213563, "Management of Type 2 Diabetes After Gastric Bypass Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01213563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*